Endo Flashcards
HbA1c goal for high risk patients in the ICU
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
C. <8%
Normal HBA1c
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
A. <5.6%
Target weight loss among overweight DM patients
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
B. 7%
Level of glucose of prediabetics
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
E. 100-125
Level of HBA1c that needs insulin injection
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
D. 9.5%
- 3 treatments for hypoglycemia *
A. Soda drink/Dextrose/glucagon
B. Jelly/ hypoglycemic drug/ dextrose
C. Glucagon/ dextrose/ protein bar
D. Soda/ dextrose/ brewed coffee
A. Soda drink/Dextrose/glucagon
- Agents which increase the amount of insulin secreted in pancreas *
A. biguanide
B. sulfonylureas
C. Acarbose
D. Amylin
B. sulfonylureas
Secretagogues:
Sulfonyureas
Meglitides
- Top 3 considerations in Drug therapy *
A. Price, efficacy, place in therapy
B. Hypoglycemia risk, price, efficacy
C. Place in therapy, efficacy, hypoglycemia risk
D. Efficacy, Price, hypoglycemia risk
C. Place in therapy, efficacy, hypoglycemia risk
- Effect of combination of metformin and IV media contrast *
A. Lactic Acidosis
B. Hyperventilation
C. Rebound hyperglycemia
D. Vomiting
A. Lactic Acidosis
- How many generations does Sulfonylureas have? *
A. 1
B. 2
C. 3
D. 4
C. 3
- 3 features of metformin *
A. first line/ gluconeogenesis/ weight loss
B. low cost/ weight loss/ second line
C. gluconeogenesis/ low cost/ weight gain
D. first line/ low cost/ lipolysis
A. first line/ gluconeogenesis/ weight loss
- 2 important indications of Glipizide *
A. liver disease and pediatric population
B. Reproductive age and asthma
C. Renal disease and liver disease
D. Elderly and renal impairment
D. Elderly and renal impairment
- Effect of GLP1 *
A. destroys DPP4 and GIP
B. triggers Beta to release insulin, prevents alpha from releasing glucagon
C. releases glucagon and prevents release of insulin
D. insulin sensitizer
B. triggers Beta to release insulin, prevents alpha from releasing glucagon
- Action of DPP4 Inhibitor*
A. destroys GLP1 and GIP
B. releases glucagon and prevents release of insulin
C. triggers Beta to release insulin, prevents alpha from releasing glucagon
D. insulin secretagogue
C. triggers Beta to release insulin, prevents alpha from releasing glucagon
- Drugs that are effective in decreasing HBA1c *
A. DPP4 inhibitor and SGL2 inhibitor
B. Alpha glucosidase inhibitor and amylin agonist
C. Biguanide and DPP4 inhibitor
D. Biguanide and Sulfonylureas
D. Biguanide and Sulfonylureas